InvestorsHub Logo
Followers 4
Posts 891
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Thursday, 06/27/2024 12:32:50 PM

Thursday, June 27, 2024 12:32:50 PM

Post# of 1769
NIST Partners With the Gates Foundation to Develop Breathalyzers for Malaria and Tuberculosis:

https://www.einnews.com/pr_news/723094603/nist-partners-with-the-gates-foundation-to-develop-breathalyzers-for-malaria-and-tuberculosis

"Breath-based diagnostics may soon be used to identify or monitor the progression of a wide range of conditions and diseases, including liver disease, multiple sclerosis and cancer."

In recent years, scientists have begun identifying biomarkers in human breath — a so-called breathprint — that indicate when someone's been infected by malaria or TB. By developing sensors that can detect these biomarkers, researchers hope to build low-cost, easily deployable breathalyzers that can be used globally.

So much potential for a wide array of tests and conditions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News